The Impact of Temporary Ovarian Ischemia due to Uterine Turnicate application at the time of Myomectomy

The Impact of Temporary Ovarian Ischemia due to Uterine Turnicate application at the time of Myomectomy: Before-after study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016050723666N2

Enrollment

Registered

2016-08-13

Start date

2016-06-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myomectomy. Acute inflammatory disease of uterus

Interventions

Intervention: Myomectomy surgery (uterine artery ligation)

Intervention: Myomectomy surgery (uterine artery ligation).

Diagnosis

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Lack of infertility in patients with ovarian factor, No Poly Cystic Ovary, No endometriosis, Body Mass Index <30, Regular menstrual pattern, An informed consent for inclusion Exclusion criteria: No informed consent for inclusion, Patients that their physician determines that treatment could be associated with risk.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anti Mullerian Hormone. Timepoint: Before and 3 months after surgery. Method of measurement: Bleeding sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Mehdizadehkashi

Iran University of Medical Science

amehdizadehkashi@yahoo.com+98 21 6650 9283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026